Dai YH - Search Results

1

Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study).

Dai YH, Yu XJ, Xu HT, Zhuang L, Zhang MS, Zou YM, Fu Q, Qiu H, Yuan XL. Dai YH, et al. Ther Adv Med Oncol. 2022 Aug 12;14:17588359221118020. doi: 10.1177/17588359221118020. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35983025 Free PMC article.

2

Suppression of CEP55 reduces cell viability and induces apoptosis in human lung cancer.

Liu L, Mei Q, Zhao J, Dai Y, Fu Q. Liu L, et al. Oncol Rep. 2016 Oct;36(4):1939-1945. doi: 10.3892/or.2016.5059. Epub 2016 Aug 31. Oncol Rep. 2016. PMID: 27633074

3

RETRACTED: Effects of lentivirus-mediated silencing of Periostin on tumor microenvironment and bone metastasis via the integrin-signaling pathway in lung cancer.

Che J, Shen WZ, Deng Y, Dai YH, Liao YD, Yuan XL, Zhang P. Che J, et al. Among authors: dai yh. Life Sci. 2017 Aug 1;182:10-21. doi: 10.1016/j.lfs.2017.05.030. Epub 2017 Jun 7. Life Sci. 2017. Retraction in: Life Sci. 2023 May 15;321:121604. doi: 10.1016/j.lfs.2023.121604 PMID: 28601389 Retracted.

4

FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway.

Huang T, Liu D, Wang Y, Li P, Sun L, Xiong H, Dai Y, Zou M, Yuan X, Qiu H. Huang T, et al. Cell Physiol Biochem. 2018;50(4):1332-1345. doi: 10.1159/000494590. Epub 2018 Oct 24. Cell Physiol Biochem. 2018. PMID: 30355943 Free article.

5

[Role of oncologic radiotherapy in multidisciplinary team treatment of malignant acute abdomen].

Dai Y, Qiu H. Dai Y, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Nov 25;21(11):1212-1217. Zhonghua Wei Chang Wai Ke Za Zhi. 2018. PMID: 30506530 Chinese.

6

AFP-producing hepatoid adenocarcinoma (HAC) of peritoneum and omentum: a case report and literature review.

Zou M, Li Y, Dai Y, Sun L, Huang T, Yuan X, Qiu H. Zou M, et al. Onco Targets Ther. 2019 Sep 18;12:7649-7654. doi: 10.2147/OTT.S216501. eCollection 2019. Onco Targets Ther. 2019. PMID: 31571915 Free PMC article.

7

Pyrotinib enhances the radiosensitivity of HER2‑overexpressing gastric and breast cancer cells.

Huang T, Luo X, Wu B, Peng P, Dai Y, Hu G, Qiu H, Yuan X. Huang T, et al. Oncol Rep. 2020 Dec;44(6):2634-2644. doi: 10.3892/or.2020.7820. Epub 2020 Oct 21. Oncol Rep. 2020. PMID: 33125154 Free PMC article.

8

Efficacy and safety of low-dose apatinib plus S-1 versus regorafenib and fruquintinib for refractory metastatic colorectal cancer: a retrospective cohort study.

Dai Y, Sun L, Zhuang L, Zhang M, Zou Y, Yuan X, Qiu H. Dai Y, et al. J Gastrointest Oncol. 2022 Apr;13(2):722-731. doi: 10.21037/jgo-22-285. J Gastrointest Oncol. 2022. PMID: 35557597 Free PMC article.

9

FGFR2 upregulates PAI-1 via JAK2/STAT3 signaling to induce M2 polarization of macrophages in colorectal cancer.

Li Y, Shi Y, Zhang X, Li P, Ma L, Hu P, Xu L, Dai Y, Xia S, Qiu H. Li Y, et al. Biochim Biophys Acta Mol Basis Dis. 2023 Apr;1869(4):166665. doi: 10.1016/j.bbadis.2023.166665. Epub 2023 Feb 11. Biochim Biophys Acta Mol Basis Dis. 2023. PMID: 36781088 Free article.

10

Retraction notice to "Effects of lentivirus-mediated silencing of Periostin on tumor microenvironment and bone metastasis via the integrin-signaling pathway in lung cancer" [Life Sci. 182 (2017) 10-21].

Che J, Shen WZ, Deng Y, Dai YH, Liao YD, Yuan XL, Zhang P. Che J, et al. Among authors: dai yh. Life Sci. 2023 May 15;321:121604. doi: 10.1016/j.lfs.2023.121604. Epub 2023 Mar 27. Life Sci. 2023. PMID: 36990904 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters